Aehr Test Systems short interest in 2022
In 2022, Aehr Test Systems's disclosed short interest ran from 8.18% of shares outstanding on 14 Jan 2022 to 16.65% on 30 Dec 2022, a change of +8.47 percentage points. The year's high was 17.54% on 30 Nov 2022 and its low 3.76% on 15 Jul 2022, averaging 9.14% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.84 days on 30 Dec 2022. Full history: Aehr Test Systems.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 8.18% (14 Jan 2022)
- End of year
- 16.65% (30 Dec 2022)
- Change
- +8.47 pp
- High
- 17.54% (30 Nov 2022)
- Low
- 3.76% (15 Jul 2022)
- Average
- 9.14%
- Highest days to cover
- 4.84 (30 Dec 2022)
- SEC filings marked
- 7
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 8.18% | 1.09 | results (8-K), 10-Q filed |
| 31 Jan 2022 | 7.74% | 1.75 | |
| 15 Feb 2022 | 8.83% | 3.06 | |
| 28 Feb 2022 | 8.47% | 3.69 | |
| 15 Mar 2022 | 8.05% | 2.91 | |
| 31 Mar 2022 | 7.48% | 3.04 | results (8-K) |
| 14 Apr 2022 | 7.17% | 2.65 | 10-Q filed |
| 29 Apr 2022 | 6.56% | 3.39 | |
| 13 May 2022 | 6.13% | 3.52 | |
| 31 May 2022 | 5.51% | 4.28 | |
| 15 Jun 2022 | 4.46% | 4.00 | |
| 30 Jun 2022 | 3.83% | 4.63 | |
| 15 Jul 2022 | 3.76% | 2.76 | |
| 29 Jul 2022 | 5.60% | 1.14 | |
| 15 Aug 2022 | 7.12% | 1.18 | |
| 31 Aug 2022 | 6.90% | 1.22 | 10-K filed |
| 15 Sep 2022 | 8.60% | 1.77 | |
| 30 Sep 2022 | 10.76% | 3.24 | |
| 14 Oct 2022 | 12.51% | 1.35 | results (8-K), 10-Q filed |
| 31 Oct 2022 | 15.81% | 1.76 | |
| 15 Nov 2022 | 14.68% | 2.40 | |
| 30 Nov 2022 | 17.54% | 4.35 | |
| 15 Dec 2022 | 17.02% | 3.65 | |
| 30 Dec 2022 | 16.65% | 4.84 |
See also: Aehr Test Systems's full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.